United States · FDA National Drug Code directory
Claritin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11523-7160_4536cd82-d67c-56be-e063-6294a90a7775
- Product NDC
- 11523-7160
- Form
- TABLET
- Composition / generic term
- Loratadine
- Labeler
- Bayer HealthCare LLC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 19930412
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (11523-7160-1) / 5 TABLET in 1 BLISTER PACK · 11523-7160-1
- 1 BLISTER PACK in 1 CARTON (11523-7160-2) / 10 TABLET in 1 BLISTER PACK · 11523-7160-2
- 2 BLISTER PACK in 1 CARTON (11523-7160-3) / 10 TABLET in 1 BLISTER PACK · 11523-7160-3
- 3 BLISTER PACK in 1 CARTON (11523-7160-5) / 10 TABLET in 1 BLISTER PACK · 11523-7160-5
- 1 POUCH in 1 CARTON (11523-7160-6) / 2 TABLET in 1 POUCH · 11523-7160-6
- 1 BLISTER PACK in 1 POUCH (11523-7160-7) / 1 TABLET in 1 BLISTER PACK · 11523-7160-7
- 1 BOTTLE in 1 CARTON (11523-7160-8) / 60 TABLET in 1 BOTTLE · 11523-7160-8
- 1 BOTTLE in 1 CARTON (11523-7160-9) / 60 TABLET in 1 BOTTLE · 11523-7160-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →